Anixa Biosciences's Total Assets for the quarter that ended in Apr. 2024 was $24.36 Mil.
During the past 12 months, Anixa Biosciences's average Total Assets Growth Rate was 79.10% per year.
During the past 3 years, the average Total Assets Growth Rate was 61.80% per year.
During the past 5 years, the average Total Assets Growth Rate was 7.80% per year.
During the past 10 years, the average Total Assets Growth Rate was -17.20% per year.
During the past 13 years, Anixa Biosciences's highest 3-Year average Total Assets Growth Rate was 168.00%. The lowest was -46.90%. And the median was -14.30%.
The historical data trend for Anixa Biosciences's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Anixa Biosciences's Total Assets for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anixa Biosciences (NAS:ANIX) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Apr. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Anixa Biosciences's Asset Turnover for the quarter that ended in Apr. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Anixa Biosciences Total Assets Related Terms
Thank you for viewing the detailed overview of Anixa Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Anixa Biosciences (Anixa Biosciences) Business Description
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANIX has been successfully added to your 